Hepatitis E primary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 8: Line 8:
As almost all [[HEV infection]]s are spread by the faecal - oral route, improving [[sanitation]] is the most important measure good personal hygiene. High quality standards for public water supplies and proper disposal of sanitary waste have resulted in a low prevalence of [[HEV infection]]s in many well developed societies.<ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>
As almost all [[HEV infection]]s are spread by the faecal - oral route, improving [[sanitation]] is the most important measure good personal hygiene. High quality standards for public water supplies and proper disposal of sanitary waste have resulted in a low prevalence of [[HEV infection]]s in many well developed societies.<ref>{{cite book | last = Mandell | first = Gerald | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Churchill Livingstone/Elsevier | location = Philadelphia, PA | year = 2010 | isbn = 0443068399 }}</ref>


For travellers to high [[endemic]] areas, the usual elementary food hygiene precautions are recommended. These include:
For travellers to high [[endemic]] areas, the usual elementary food hygiene precautions are recommended. These include:<ref name=WHO>{{cite web | title = Hepatitis E | url = http://www.who.int/csr/disease/hepatitis/whocdscsredc200112/en/index5.html }}</ref>
*Avoiding drinking water and/or ice of unknown purity
*Avoiding drinking water and/or ice of unknown purity
*Eating uncooked shellfish, uncooked fruits or vegetables that are not peeled or prepared by the traveller
*Eating uncooked shellfish, uncooked fruits or vegetables that are not peeled or prepared by the traveller
Line 20: Line 20:


==Vaccination==
==Vaccination==
A vaccine based on recombinant viral proteins has been developed and recently tested in a high-risk population (military personnel of a developing country).<ref>{{cite journal |author=Shrestha MP, Scott RM, Joshi DM, ''et al'' |title=Safety and efficacy of a recombinant hepatitis E vaccine |journal=N. Engl. J. Med. |volume=356 |issue=9 |pages=895-903 |year=2007 |pmid=17329696 |doi=10.1056/NEJMoa061847}}</ref> The vaccine appeared to be effective and safe, but further studies are needed to assess the long-term protection and the cost-effectiveness of hepatitis E vaccination.
A [[vaccine]] based on recombinant [[viral]] proteins has been developed, and recently tested in a high-risk population (military personnel of a developing country).<ref>{{cite journal |author=Shrestha MP, Scott RM, Joshi DM, ''et al'' |title=Safety and efficacy of a recombinant hepatitis E vaccine |journal=N. Engl. J. Med. |volume=356 |issue=9 |pages=895-903 |year=2007 |pmid=17329696 |doi=10.1056/NEJMoa061847}}</ref> The [[vaccine]] appeared to be effective and safe, but further studies are needed to assess the long-term protection and the cost-effectiveness of hepatitis E vaccination.


==References==
==References==

Revision as of 16:24, 25 August 2014

Hepatitis E Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatitis E from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Hepatitis E primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatitis E primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatitis E primary prevention

CDC on Hepatitis E primary prevention

Hepatitis E primary prevention in the news

Blogs on Hepatitis E primary prevention

Directions to Hospitals Treating Hepatitis E

Risk calculators and risk factors for Hepatitis E primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Prevention

As almost all HEV infections are spread by the faecal - oral route, improving sanitation is the most important measure good personal hygiene. High quality standards for public water supplies and proper disposal of sanitary waste have resulted in a low prevalence of HEV infections in many well developed societies.[1]

For travellers to high endemic areas, the usual elementary food hygiene precautions are recommended. These include:[2]

  • Avoiding drinking water and/or ice of unknown purity
  • Eating uncooked shellfish, uncooked fruits or vegetables that are not peeled or prepared by the traveller

Guidelines for Epidemic Measures

The following measures should be observed in an epidemic situation:[2]

  • Determination of the mode of transmission
  • Identification of the population with an increased risk of infection
  • Elimination of a common source of infection
  • Improvement of sanitary and hygienic practices to eliminate faecal contamination of food and water

Vaccination

A vaccine based on recombinant viral proteins has been developed, and recently tested in a high-risk population (military personnel of a developing country).[3] The vaccine appeared to be effective and safe, but further studies are needed to assess the long-term protection and the cost-effectiveness of hepatitis E vaccination.

References

  1. Mandell, Gerald (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Churchill Livingstone/Elsevier. ISBN 0443068399.
  2. 2.0 2.1 "Hepatitis E".
  3. Shrestha MP, Scott RM, Joshi DM; et al. (2007). "Safety and efficacy of a recombinant hepatitis E vaccine". N. Engl. J. Med. 356 (9): 895–903. doi:10.1056/NEJMoa061847. PMID 17329696.

Template:WS Template:WH